Bristol Myers Squibb reported $5.71B in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 3042M 769M
ALKERMES ALKS:US $ -0.27M 23.16M
Amgen AMGN:US $ 3228M 40M
Astrazeneca AZN:US $ 2784M 588M
AstraZeneca AZN:LN 2784M 588M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5712M 33M
Catalent CTLT:US $ 222M 104.3M
Coherus Biosciences CHRS:US $ -31.9M 8.61M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Endo International Ordinary Shares ENDP:US $ 320.03M 5.28M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Horizon Pharma HZNP:US $ 439.93M 134.24M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
JAZZ PHA JAZZ:US $ 195.95M 118.22M
Johnson & Johnson JNJ:US $ 8192M 2043M
Lannett LCI:US $ -4.15M 8.72M
Medtronic MDT:US $ 2283M 268M
Novartis NOVN:VX SF 4837M 65M
Perrigo Ordinary Shares PRGO:US $ 527.9M 408.9M
Pfizer PFE:US $ 10235M 2245M
Phibro Animal Health PAHC:US $ 22.47M 4.54M
Prestige Brands PBH:US $ 86.52M 12.42M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Revance Therapeutics RVNC:US $ -67.57M 2.28M
Teva Pharmaceutical Industries TEVA:US $ 1137M 1M
United Therapeutics UTHR:US $ 242.3M 7.7M
Zoetis ZTS:US $ 845M 7M